Standout Papers

Lung Cancer 2007 2026 2013 2019 1.9k
  1. Lung Cancer (2008)
    Roy S. Herbst, John V. Heymach et al. New England Journal of Medicine
  2. Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data (2019)
    Charles M. Rudin, John T. Poirier et al. Nature reviews. Cancer
  3. Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy (2019)
    Ferdinandos Skoulidis, John V. Heymach Nature reviews. Cancer
  4. PF00299804, an Irreversible Pan-ERBB Inhibitor, Is Effective in Lung Cancer Models with EGFR and ERBB2 Mutations that Are Resistant to Gefitinib (2007)
    Jeffrey A. Engelman, Kreshnik Zejnullahu et al. Cancer Research
  5. Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer (2019)
    Triparna Sen, B. Leticia Rodriguez et al. Cancer Discovery
  6. Epithelial–Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma (2016)
    Yanyan Lou, Lixia Diao et al. Clinical Cancer Research
  7. Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials (2020)
    Willemijn S.M.E. Theelen, Dawei Chen et al. The Lancet Respiratory Medicine
  8. Combining Radiation and Immunotherapy: A New Systemic Therapy for Solid Tumors? (2014)
    Chad Tang, Xiaohong Wang et al. Cancer Immunology Research
  9. Molecular Mechanisms and Future Implications of VEGF/VEGFR in Cancer Therapy (2022)
    Sonia Patel, Monique B. Nilsson et al. Clinical Cancer Research
  10. Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non–Small-Cell Lung Cancer (2018)
    Zhongxing Liao, J. Jack Lee et al. Journal of Clinical Oncology
  11. AI in drug discovery and its clinical relevance (2023)
    Rizwan Qureshi, Muhammad Irfan et al. Heliyon
  12. Non-small-cell lung cancer (2024)
    Lizza Hendriks, Jordi Remón et al. Nature Reviews Disease Primers
  13. Antibody-drug conjugates in lung cancer: dawn of a new era? (2023)
    Niamh Coleman, Timothy A. Yap et al. npj Precision Oncology

Immediate Impact

14 by Nobel laureates 29 from Science/Nature 97 standout
Sub-graph 1 of 19

Citing Papers

New promises and challenges in the treatment of advanced non-small-cell lung cancer
2024 Standout
Naturally occurring T cell mutations enhance engineered T cell therapies
2024 StandoutNature
8 intermediate papers

Works of John V. Heymach being referenced

HER4 and EGFR Activate Cell Signaling in NRG1 Fusion-Driven Cancers: Implications for HER2-HER3-specific Versus Pan-HER Targeting Strategies
2023
High OX-40 expression in the tumor immune infiltrate is a favorable prognostic factor of overall survival in non-small cell lung cancer
2019 Nobel
and 12 more

Author Peers

Author Last Decade Papers Cites
John V. Heymach 13200 9865 10839 623 24.3k
Giampaolo Tortora 13500 7644 9748 619 23.7k
Kenneth J. O’Byrne 12402 10276 8206 586 23.0k
David S. Hong 10195 6145 9319 810 22.5k
Luis Paz‐Ares 12823 11087 7419 681 22.1k
Suresh S. Ramalingam 15160 14115 8642 584 24.7k
Manuel Hidalgo 18199 6919 12346 443 29.1k
Peter J. O’Dwyer 12800 5123 9732 394 23.0k
Martin Gore 14140 8895 12791 377 29.0k
Geoffrey I. Shapiro 12576 7630 12589 493 22.4k
Ravi Salgia 10406 8256 12218 618 26.9k

All Works

Loading papers...

Rankless by CCL
2026